Stockscreener 앱 받기
1.13
0.89%
0.010
시간 외 거래:
1.10
-0.03
-2.65%
전일 마감가:
$1.12
열려 있는:
$1.12
하루 거래량:
365.57K
Relative Volume:
0.06
시가총액:
$25.31M
수익:
-
순이익/손실:
$-16.28M
주가수익비율:
-0.0812
EPS:
-13.91
순현금흐름:
$-13.75M
1주 성능:
+0.00%
1개월 성능:
+60.76%
6개월 성능:
+36.28%
1년 성능:
-57.68%
1일 변동 폭
$1.09
$1.15
1주일 범위
$1.09
$1.23
52주 변동 폭
$0.281
$3.85
Pasithea Therapeutics Corp Stock (KTTA) Company Profile
명칭
Pasithea Therapeutics Corp
전화
(702) 514-4174
주소
1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH
KTTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KTTA
Pasithea Therapeutics Corp
|
1.13 | 25.09M | 0 | -16.28M | -13.75M | -13.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pasithea Therapeutics Corp 주식(KTTA)의 최신 뉴스
Market Review: Is Pasithea Therapeutics Corp stock a contrarian buy2025 Top Gainers & Safe Capital Allocation Plans - moha.gov.vn
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Pasithea Therapeutics Corp - GuruFocus
Pasithea Therapeutics (NASDAQ:KTTA) Upgraded at Zacks Research - Defense World
Pasithea Therapeutics Corp. (KTTA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Did KTTA Stock Soar A Whopping 48% Today? - MSN
What is HC Wainwright’s Forecast for KTTA FY2025 Earnings? - Defense World
HC Wainwright Begins Coverage on Pasithea Therapeutics (NASDAQ:KTTA) - Defense World
There is no way Pasithea Therapeutics Corp (KTTA) can keep these numbers up - setenews.com
Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright By Investing.com - Investing.com Nigeria
HC Wainwright & Co. Initiates Coverage of Pasithea Therapeutics (KTTA) with Buy Recommendation - Nasdaq
Pasithea Therapeutics stock initiated with Buy rating at H.C. Wainwright - Investing.com
HC Wainwright Initiates Coverage on Pasithea Therapeutics With Buy Rating, $3 Price Target - marketscreener.com
Is Pasithea Therapeutics Corp. stock attractive for hedge funds2025 Top Decliners & Technical Confirmation Trade Alerts - Newser
Small Cap Stocks To ConsiderNovember 30th - MarketBeat
Will Pasithea Therapeutics Corp. Equity Warrant stock benefit from commodity prices2025 Dividend Review & Weekly Top Performers Watchlists - Newser
Insiders Buying Pasithea Therapeutics Might Wish They Invested More, Stock Gains 10% - Yahoo Finance
Pasithea Therapeutics Reaches US$104m Market Cap Benefiting Insider Stock Buying - simplywall.st
Lawrence Steinman Bought 201% More Shares In Pasithea Therapeutics - Yahoo Finance
Will Pasithea Therapeutics Deliver On Clinical Promise Or Struggle With Funding Risks? - RTTNews
Top Biotech Stocks To Watch TodayNovember 29th - MarketBeat
Small Cap Stocks To Follow NowNovember 29th - MarketBeat
Best Small Cap Stocks To Keep An Eye OnNovember 28th - MarketBeat
Pasithea Therapeutics Completes $60M Public Offering - TipRanks
Best Penny Stocks To Watch TodayNovember 29th - MarketBeat
Pasithea Therapeutics announces closing of $60 million public offering of common stock - marketscreener.com
Pasithea Therapeutics (Nasdaq: KTTA) raises $60M, extends cash runway into 2028 - Stock Titan
Promising Penny Stocks To Consider – November 30th - Defense World
Small Cap Stocks To Consider – November 30th - Defense World
Published on: 2025-12-02 03:15:38 - Newser
Biotech Stocks To Watch Today – November 30th - Defense World
Pasithea Therapeutics (KTTA) Stock Analysis Report | Financials & Insights - Benzinga
Insider Buying Spree at Pasithea Therapeutics: Top Executives Invest Big! - TipRanks
Biotech Stocks To Watch TodayNovember 30th - MarketBeat
Pasithea Therapeutics Stock (KTTA) Opinions on PAS-004 Drug Updates - Quiver Quantitative
Pasithea therapeutics (KTTA) director Steinman buys $99,999 in stock By Investing.com - Investing.com Canada
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares By Investing.com - Investing.com Canada
Marques buys Pasithea Therapeutics (KTTA) shares worth $24999 By Investing.com - Investing.com Canada
Pasithea therapeutics (KTTA) director Steinman buys $99,999 in stock - Investing.com India
Dumesnil Simon buys Pasithea Therapeutics (KTTA) shares - Investing.com
Marques buys Pasithea Therapeutics (KTTA) shares worth $24999 - Investing.com
Pasithea Therapeutics Executives and Directors Make Significant Stock Purchases - TradingView — Track All Markets
Dir Dumesnil Buys 33,333 ($25K) Of Pasithea Therapeutics Corp [KTTA] - TradingView
Ready to Jump After Recent Trade: Pasithea Therapeutics Corp (KTTA) - Setenews
Pasithea Prices $60 Mln Offering To Advance PAS-004 And Broader Pipeline - Nasdaq
Top Biotech Stocks To Watch Today – November 29th - Defense World
Pasithea Therapeutics Reports Positive Phase 1 Data for PAS-004 - MSN
Pasithea Therapeutics Corp (KTTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Pasithea Therapeutics Corp 주식 (KTTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Marques Tiago | Chief Executive Officer |
Nov 28 '25 |
Buy |
0.75 |
33,333 |
25,000 |
73,334 |
| Dumesnil Simon | Director |
Nov 28 '25 |
Buy |
0.75 |
33,333 |
25,000 |
35,833 |
1.08%
0.91%
자본화:
|
볼륨(24시간):